Priscilla F. Mcauliffe, MD, PhD | Authors

How to Maximize the Potential of mTOR Inhibitors in Breast Cancer-More Questions Than Answers

January 15, 2013

Such a systematic review of the current status of mTOR inhibitors in the treatment of breast cancer demonstrates holes in our knowledge of the role of the tumor, the host, and metabolic factors in breast cancer progression.